Henan Lingrui Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Henan Lingrui Pharmaceutical Co Ltd cash flow reinvestment rate. Henan Lingrui Pharmaceutical Co Ltd (600285) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting CN¥5.61 Million (capex CN¥5.61 Million ) from operating cash flow of CN¥140.12 Million. Explore debt repayment capacity of Henan Lingrui Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Henan Lingrui Pharmaceutical Co Ltd (1999–2025)
Cash flow reinvestment rate of Henan Lingrui Pharmaceutical Co Ltd from 1999 to 2025. Historical reinvestment intensity for Henan Lingrui Pharmaceutical Co Ltd across 26 annual periods. Explore how much does Henan Lingrui Pharmaceutical Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Henan Lingrui Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (1999–2025)
Henan Lingrui Pharmaceutical Co Ltd cash flow reinvestment rate by year from 1999 to 2025. Year-by-year capital reinvestment analysis for Henan Lingrui Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Henan Lingrui Pharmaceutical Co Ltd operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥100.28 Million | CN¥553.88 Million | CN¥56.83 Million | ▼ -1.5% |
| 2024 | 0.18x | CN¥160.97 Million | CN¥875.86 Million | CN¥115.11 Million | ▼ -40.4% |
| 2023 | 0.31x | CN¥250.90 Million | CN¥813.43 Million | CN¥21.20 Million | ▲ +132.4% |
| 2022 | 0.13x | CN¥110.81 Million | CN¥834.91 Million | CN¥26.99 Million | ▼ -80.0% |
| 2021 | 0.66x | CN¥559.89 Million | CN¥845.69 Million | CN¥76.91 Million | ▲ +102.2% |
| 2020 | 0.33x | CN¥147.49 Million | CN¥450.53 Million | CN¥71.82 Million | ▼ -32.2% |
| 2019 | 0.48x | CN¥217.21 Million | CN¥450.15 Million | CN¥59.04 Million | ▼ -21.7% |
| 2018 | 0.62x | CN¥268.93 Million | CN¥436.25 Million | CN¥52.14 Million | ▼ -76.2% |
| 2017 | 2.59x | CN¥274.71 Million | CN¥105.97 Million | CN¥257.55 Million | ▼ -33.6% |
| 2016 | 3.90x | CN¥246.94 Million | CN¥63.26 Million | CN¥218.05 Million | ▲ +431.7% |
| 2015 | 0.73x | CN¥115.12 Million | CN¥156.82 Million | CN¥84.23 Million | ▼ -10.6% |
| 2014 | 0.82x | CN¥102.10 Million | CN¥124.32 Million | CN¥102.10 Million | ▼ -37.4% |
| 2013 | 1.31x | CN¥166.88 Million | CN¥127.27 Million | CN¥166.88 Million | ▼ -79.9% |
| 2012 | 6.51x | CN¥100.53 Million | CN¥15.43 Million | CN¥100.53 Million | ▲ +312.7% |
| 2011 | 1.58x | CN¥63.90 Million | CN¥40.49 Million | CN¥63.90 Million | ▲ +364.2% |
| 2009 | 0.34x | CN¥45.08 Million | CN¥132.61 Million | CN¥45.08 Million | ▼ -55.8% |
| 2008 | 0.77x | CN¥33.63 Million | CN¥43.72 Million | CN¥33.63 Million | ▼ -72.6% |
| 2007 | 2.81x | CN¥44.84 Million | CN¥15.99 Million | CN¥44.84 Million | ▲ +353.4% |
| 2006 | 0.62x | CN¥16.56 Million | CN¥26.76 Million | CN¥16.56 Million | ▲ +8.0% |
| 2005 | 0.57x | CN¥19.15 Million | CN¥33.43 Million | CN¥19.15 Million | ▼ -50.0% |
| 2004 | 1.14x | CN¥40.65 Million | CN¥35.51 Million | CN¥40.65 Million | ▼ -33.3% |
| 2003 | 1.72x | CN¥40.81 Million | CN¥23.79 Million | CN¥40.81 Million | ▲ +120.3% |
| 2002 | 0.78x | CN¥54.06 Million | CN¥69.41 Million | CN¥54.06 Million | ▼ -92.9% |
| 2001 | 10.93x | CN¥37.29 Million | CN¥3.41 Million | CN¥37.29 Million | ▲ +6.1% |
| 2000 | 10.31x | CN¥37.76 Million | CN¥3.66 Million | CN¥37.76 Million | ▲ +778.6% |
| 1999 | 1.17x | CN¥5.64 Million | CN¥4.81 Million | CN¥5.64 Million | — |